Form 4: Acacia Research Director Geoffrey Ribar Receives Annual Restricted Stock Grant
Insider Transaction Report
Acacia Research Corp. Director Geoffrey G. Ribar was granted 32,172 shares of restricted common stock as part of the company's annual equity awards for non-employee directors, vesting on the first anniversary of the grant date.
Summary
- Geoffrey G. Ribar, a Director of Acacia Research Corp. (ACTG), acquired 32,172 shares of ACTG Common Stock on May 30, 2025.
- This acquisition was a grant of restricted stock, with a reported price of $0, indicating it was an award rather than a purchase.
- The grant is part of the Company's annual equity awards program for non-employee directors, issued under the 2024 Acacia Research Corporation Stock Incentive Plan.
- The restricted stock will fully vest on the first anniversary of the grant date, which is May 30, 2026.
- Following this transaction, Mr. Ribar beneficially owns 85,827 shares of ACTG Common Stock directly.
Sentiment
Score: 6
Explanation: The sentiment is mildly positive as it represents a routine, expected compensation practice that aligns director interests with shareholders, without indicating any negative operational or financial news.
Positives
- Increases alignment of director's interests with shareholders through equity ownership.
- Part of a routine annual compensation plan for non-employee directors, indicating stable corporate governance practices.
- The grant incentivizes long-term commitment and performance from the director due to the one-year vesting period.
Negatives
- The grant of restricted stock at a $0 price does not represent a direct cash investment by the director.
- Equity grants can lead to minor share dilution over time, though this specific grant is small relative to the total outstanding shares.
Risks
- The value of the restricted stock is subject to the future market price of ACTG common stock, meaning the actual realized value upon vesting could be lower than the grant date value if the stock price declines.
- Vesting is contingent on continued service as a director for one year.
Future Outlook
NA
Industry Context
This transaction is a standard practice for public companies to compensate non-employee directors with equity, aligning their interests with shareholders. It does not provide specific insights into broader industry trends or competitive landscape beyond standard corporate compensation practices.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Compensation Policy Implementation | Grant of restricted stock to a non-employee director under the 2024 Acacia Research Corporation Stock Incentive Plan, reflecting the company's established equity compensation policy for its board. | 05/30/2025 | Reinforces alignment between director incentives and shareholder value through equity ownership, promoting long-term commitment. |
Related Party Transactions
- Grant of 32,172 shares of restricted stock to Geoffrey G. Ribar, a non-employee director, as part of his compensation.
Stakeholder Impact
- Shareholders: Increased alignment of director's interests with shareholder value. Minor potential for dilution from equity grants.
Next Steps
- The restricted stock will vest on May 30, 2026, subject to continued service.
Key Dates
| Date | Description |
|---|---|
| 05/30/2025 | Date of grant of restricted stock to Director Geoffrey G. Ribar. |
| 05/30/2026 | First anniversary of the grant date, when 100% of the restricted stock will vest. |
Keywords
Acacia Research Corp, ACTG, SEC Form 4, Insider Transaction, Restricted Stock, Equity Grant, Director Compensation, Stock Incentive Plan, Corporate Governance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.